MarketBeat
08 Aug 2026, 01:03 UTC · 6w ago
Verdict
Headline takes no side. We score CDRE +0.90 across five claims — strongly bullish.
+0.90strongly bullish
More positive than 94% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Cadre raised its full-year 2026 guidance, projecting net sales of $749M–$769M and adjusted EBITDA of $139M–$144M.
More positive than 99% of claims this week
The company reported a record orders backlog for the second consecutive quarter, with significant increases in nuclear operations and armor.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 92% of claims this week
Second-quarter net sales rose 32% year-over-year to $207.1 million, with adjusted EBITDA increasing by 56%.
So whatStrong current-quarter performance validates the growth strategy and supports the raised guidance.
More positive than 85% of claims this week
Cadre is pursuing a strategy of bolt-on acquisitions, having completed the Alien Gear Holsters purchase and planning at least one more acquisition in 2026.
More positive than 63% of claims this week
An executive order related to downblending created margin and mix pressure for a portion of the Alpha Safety container business.
So whatThis represents a regulatory headwind, although management noted it affects less than 8% of nuclear revenue.
More negative than 71% of claims this week
Which stocks this story touches
More positive than 94% of ticker scores this week
The company reported significant growth in sales, profitability, and backlog, and subsequently raised its full-year outlook.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−18.7%
Price is moving against the score
$26.68 vs $32.82 close before publication (Aug 7) · not market-adjusted
CDRE chart →
